Skip to main content

Company name

Promedon S.A.

Project number

14834-01

Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.

E&S category
tooltip

B

Country

Regional

Sector

Social Infrastructure

Status

In implementation

Disclosed date

05/24/2024

Projected date at which a project will be put forward for the Board of Executive Directors’ approval.

Projected board date
tooltip

10/28/2024

Approval date

10/28/2024

Signed date

12/02/2024

Sponsoring entity

N/A

Investment Operations Department Contact

Infrastructure and Energy Division

Investment type

Syndicated amount

N/A

Financing amount

USD $ 15,000,000

Currency

USD

Project scope and objective

Founded in 1985 in Argentina, Promedon is a leading company in the manufacturing and distribution of high-complexity medical devices, especially in the fields of urology, arthroscopy, gastrointestinal endoscopy, and neurosurgery. Currently, the Promedon Group operates directly in Latin America in Brazil, Chile, Mexico, and Argentina, and in Europe in Germany, Austria, Switzerland, Sweden, Spain, the Netherlands, and Portugal. The proposed operation consists of a medium-term loan to the Company for the development of new products and medical equipment, including clinical trials and product registration in various markets.

For inquiries, comments and information requests about the project

Request information

Learn more about how we provide private-sector solutions in the region .

Environmental and social review

IDB Invest conducts an environmental and social due diligence (ESDD) commensurate with the nature, scale, and stage of the project, and with its level of environmental and social risks and impacts. The ESDD will confirm the project E&S categorization and assess the project with respect to the client requirements in IDB Invest Environmental and Social Sustainability Policy. The results of the ESDD, including any identified gaps are described in the Environmental and Social Review Summary (ESRS) provided below. For projects approved as of 2016, any gaps with respect to IDB Invest's Environmental and Social Sustainability Policy at the time of the ESDD are addressed in the Environmental and Social Action Plan (ESAP) presented below, to comply with the date mentioned above.

SUPPORTING PRODUCTION AND EXPORTS OF MEDICAL EQUIPMENT WITH PROMEDON - ENVIRONMENTAL AND SOCIAL ACTION PLAN (ESAP OR PAAS)

378.9 Kb

SUPPORTING PRODUCTION AND EXPORTS OF MEDICAL EQUIPMENT WITH PROMEDON - ENVIRONMENTAL AND SOCIAL REVIEW SUMMARY (ESRS OR RRAS)

1013.8 Kb

For inquiries, comments and information requests about the project

Request information

Learn more about how we provide private-sector solutions in the region .

Contact information

For inquiries, comments and information requests about the project

Request information

Alternatively, you may also use the following contact information :

Client Contact

EMAIL

fedediaz74@gmail.com

PHONE NUMBER

0800 555-2500

POST OFFICE ADDRESS

Av. Libertador 7270 – Piso 8º Libertador Office Plaza 1429 – Capital Federal – BsAs

IDB Invest Contact

EMAIL

requestinformation@idbinvest.org

PHONE

+1(202)-566-4566

ADDRESS

1350 New York Ave NW, Washington, DC 20005

For inquiries, comments and information requests about the project

Request information

Learn more about how we provide private-sector solutions in the region .